Michael Thomas Henderson, Chief Executive Officer at Apogee Therapeutics, Inc. (APGE), sold 20,000 shares at $78.64 ($1.6M) on 2026-01-14, disclosed to the SEC on 2026-01-16.
Open-market sale of $1.6M APGE by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.64 | 1,440 | $113K | 7.0% |
| 2 | $79.82 | 8,476 | $677K | 41.7% |
| 3 | $81.00 | 2,374 | $192K | 11.9% |
| 4 | $82.41 | 1,854 | $153K | 9.4% |
| 5 | $83.16 | 5,386 | $448K | 27.6% |
| 6 | $83.79 | 470 |
| $39K |
| 2.4% |
| Total | $81.11 avg | 20,000 | $1.6M | 100% |
| Filing → |
| SYRE | SELL | 2026-06-23 | $2.0M | — | Filing → |
| APGE | SELL | 2026-06-12 | $1.7M | — | Filing → |
| APGE | SELL | 2026-05-15 | $1.6M | — | Filing → |